'Blue-sky' oyster vaccine has global potential say scientists

'Blue-sky' oyster vaccine has global potential say scientists
The Pacific oyster industry has struggled with a deadly virus since 2010. (Image: Moana NZ)
Greg Hurrell
The newest research into fighting a virus that devastated New Zealand’s multimillion-dollar Pacific oyster industry has global commercial potential despite its novel and “blue-sky nature”, scientists say.Nelson's independent Cawthron Institute has been granted $1 million over three years from the Endeavour Fund to develop a practical vaccine for Pacific oyster mortality syndrome (Poms), a goal previously thought impossible for shellfish.The Ministry of Business, Innovation and Employment (MBIE) administers the fund.The gra...

More Primary Sector

Fonterra on India: no dairy, no deal
Primary Sector

Fonterra on India: no dairy, no deal

Co-op says it "wouldn't be acceptable" to sign an India trade deal excluding dairy.

Fonterra's white flag over white gold
Primary Sector

Dileepa Fonseka: Fonterra's white flag over white gold

Fonterra waves the white flag in the national quest for 'value add'.

Analysts upbeat about Scales lifting its apple game
Primary Sector

Analysts upbeat about Scales lifting its apple game

The deal with Bostock Group promises to deliver more premium fruit for Mr Apple.

Jarden: $2 per share capital return possible if Fonterra gets full price for consumer business
Primary Sector

Jarden: $2 per share capital return possible if Fonterra gets full price for consumer business

Analyst believes a sale worth $3.4b all up is in the 'realms of possibility'.

Riley Kennedy 17 May 2024